Quretech Bio
Pre-clinicalQureTech Bio are addressing a significant unmet medical need by developing a new class of antibacterial agents that target antimicrobial resistance.
Focus
Small Molecules
About
QureTech Bio are addressing a significant unmet medical need by developing a new class of antibacterial agents that target antimicrobial resistance.
Funding History
1Total raised: $3.2M
Seed$3.2MUndisclosedMay 15, 2023
Company Info
TypePrivate
LocationSweden
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Basic Genomics
Pre-clinical · Stockholm
2A Pharma
Phase 1 · Stockholm
Abliva
Pre-clinical · Lund
Affibody
Phase 1 · Solna
Alligator Bioscience
Phase 1 · Lund
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile